Clinical Anesthesia Mastery Form
for Anesthesia Technician Students - Adult Patients (3rd Edition)
This application is designed as an educational training support tool for anesthesia technicians and trainees.
⚠️ Operating Room Safety Agreement
- Wear appropriate attire: scrubs, head cover, and slippers
- Stay quiet and maintain a professional demeanor
- Do not touch anything unless explicitly permitted
- Always ask permission before assisting
- Wash your hands regularly and follow sterile protocols
Anesthesia Medication Categories:
📚 The Six A's of Pre-Anesthetic Medications:
- Anxiolysis: Reducing patient anxiety and fear before surgery using benzodiazepines like midazolam, diazepam, or lorazepam
- Amnesia: Providing lack of memory of events surrounding surgery (secondary effect of anxiolytics like lorazepam or scopolamine)
- Antiemetic: Preventing postoperative nausea and vomiting (PONV) using metoclopramide or ondansetron
- Antacid: Reducing gastric acidity to minimize aspiration risk (oral sodium citrate, ranitidine, or omeprazole)
- Anti-autonomic: Blocking unwanted reflexes - drying secretions (glycopyrrolate) or managing HR/BP (beta-blockers)
- Analgesia: Preemptive pain relief with opioids (morphine, pethidine, or fentanyl)
👤 Patient Information
Medical History:
Focus Areas:
📚 Mallampati Classification System:
Used to predict difficulty of intubation based on visibility of pharyngeal structures with mouth fully open and tongue protruded:
- Class I: Soft palate, fauces, uvula, and anterior & posterior tonsillar pillars visible - Easy intubation
- Class II: Soft palate, fauces, and uvula visible - Usually easy intubation
- Class III: Soft palate and base of uvula visible - Moderate difficulty
- Class IV: Only hard palate visible - Difficult intubation likely
- 3 fingers: Mouth opening (inter-incisor distance) - should accommodate 3 fingers (≥4cm)
- 3 fingers: Hyoid-mental distance (thyromental distance) - ≥3 fingers (≥6cm)
- 2 fingers: Hyoid-thyroid cartilage distance - ≥2 fingers (≥4cm)
Vital Signs (Pre-Induction):
Basic Investigations:
Additional Assessments:
📚 Common Surgical Positions:
📚 IV Cannula & Fluid Therapy Details:
Vital Signs (Post-Induction):
Ventilation Settings:
📚 Mechanical Ventilation Modes:
Vital Signs (Recovery):
Did you observe any complications and how they were managed?
PBW = 45.5 + 0.91 × (165 − 152.4) = 57 kg
Correct VT (8 mL/kg PBW) = 456 mL.
Using actual weight: 8 × 110 = 880 mL — nearly double. Always use PBW.
PCV: Pressure ramps up to the set level then holds as a plateau. Rise time controls how quickly it reaches that level.
PSV: Brief dip below PEEP when patient triggers, then rapid rise to support level.
PCV / PSV: Inspiration starts with high flow then decelerates. Expiratory flow decays back to zero.
Key rule: If expiratory flow does not return to zero before the next breath, air is trapped.
VCV: Linear rise (constant flow). PCV/PSV: Curved rise — fast initially as flow peaks, then slowing near the end of inspiration.
PCV-VG: Pressure adjusts breath-to-breath — VT stays consistent, but the pressure waveform height visibly changes.
High PIP and high Pplat → Lung is stiff (pneumothorax, pulmonary oedema, surgical position)
Both readings together help the anaesthetist find the cause.
High Pplat → inform anaesthetist immediately. Do not adjust settings independently.
Mandatory monitoring for all intubated patients. The ETCO₂ value (normally 35–45 mmHg) reflects how much CO₂ is being exhaled. A normal capnogram rises at the start of exhalation, forms a near-flat plateau, then drops to zero with the next breath.
Four signs to recognise:
- Sudden drop to zero → Disconnection, oesophageal intubation, or cardiac arrest. Treat as emergency.
- Gradual rise → Under-ventilation or rising CO₂ production. Increase RR as directed.
- Baseline above zero → CO₂ rebreathing. Check absorber and valves.
- Slanted plateau → Obstructive disease (asthma). Same cause as the slow expiratory flow trace.
Full capnography waveform simulation will be available in the upcoming Enki Scalar OR & ICU module.
Selected references
- 1.The Acute Respiratory Distress Syndrome Network (ARDSNet). Ventilation with lower tidal volumes as compared with traditional tidal volumes. N Engl J Med. 2000;342(18):1301–1308.
- 2.ARDSNet. Predicted Body Weight formula and lung-protective ventilation protocol. ARMA Trial supplementary materials. 2000.
- 3.Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail's Clinical Anesthesiology, 7th ed. Chapter: Respiratory Physiology & Anesthesia.
- 4.Miller RD et al. Miller's Anesthesia, 9th ed. Elsevier. Chapter: Respiratory Function During Anesthesia.
- 5.Tobin MJ. Principles and Practice of Mechanical Ventilation, 3rd ed. McGraw-Hill. (Compliance, resistance, time constants, PEEP, waveform patterns.)
IV Drug Compatibility Checker
Quick reference for IV drug–fluid and selected drug–drug compatibility during anesthesia, OB anesthesia, PACU, and critical care.
Three-drug combinations are rarely studied. This checks each pair individually — it does not prove the three together are safe.
Important definitions
- Drug–fluid compatibility: whether a medication can be diluted or run with a fluid under specified conditions.
- Y-site compatibility: short contact in tubing. This is not the same as mixing in a syringe or bag.
- Stability: how long the prepared solution remains acceptable. Compatible does not mean stable forever.
- No data: treat as verify/avoid in training mode unless pharmacy confirms.
تنبيه: هذه الصفحة للتدريب السريري ولا تغني عن الصيدلي السريري، البروتوكول المحلي، أو النشرة الرسمية للدواء.
- ASHP Injectable Drug Information / Trissel's — preferred gold reference for final production review.
- DailyMed / FDA labels for high-risk drug-specific compatibility and stability statements.
- Manufacturer labeling where available.
- Local hospital pharmacy policy — final authority for mixtures, concentrations, and discard times.
Bibliography / المصادر المرجعية
-
Gahart's Intravenous Medications: A Handbook for Nurses and Health Professionals.
34th edition. Elsevier, 2018.
Betty L. Gahart, RN; Adrienne R. Nazareno, PharmD; Meghan Q. Ortega, RN, BSN.
غاهارت للأدوية الوريدية: دليل الممرضين والمختصين الصحيين. الطبعة الـ34. إلزيفير، 2018. -
Manufacturer labeling (DailyMed / FDA).
Referenced for drug-specific dilution, stability, and compatibility statements where available.
High-risk entries (Ceftriaxone, Piperacillin/Tazobactam, Propofol, Calcium salts, Sodium Bicarbonate, Oxytocin) cross-checked directly against official labeling.
نشرات الشركات المصنّعة (DailyMed / FDA). مرجع للتخفيف، الثبات، والتوافق لكل دواء حيث توفرت. الأدوية عالية الخطورة مقارنة مباشرةً بالنشرات الرسمية. -
ASHP Injectable Drug Information / Trissel's Handbook on Injectable Drugs.
Referenced for selected Y-site and dilution data where manufacturer labeling was insufficient or absent. Entries derived from this source are labelled ASHP-Trissel in the dataset metadata.
مرجع ASHP للأدوية الحقنية / كتيب Trissel. مرجع إضافي لبيانات Y-site والتخفيف عند غياب أو قصور نشرة الشركة. الإدخالات المستمدة منه مصنّفة ASHP-Trissel في البيانات الوصفية.
This tool does not reproduce, bundle, or link to copyrighted content. Bibliographic references are listed for transparency only. Always verify against your institutional pharmacy resources and current approved labeling.
هذه الأداة لا تنسخ أو توزّع أي محتوى محمي بحقوق النشر. المراجع مذكورة للشفافية فقط. تحقق دائماً من مصادر صيدلية مؤسستك والنشرات المعتمدة الحالية.
📝 My Clinical Notes
No notes yet!
Click below to add your first observation note📍 Section
✏️ Your observation